A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
COVID-19 · SARS-CoV-2 Infection
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
UCLA Westwood, Los Angeles, California, United States
Contact: Principal Investigator (Kara Chew, MD, MS)UCSF Community and Clinical Research Center, San Francisco, California, United States
Contact: Principal Investigator (Steven Deeks, MD)
Study leads
Kara Chew, MD, MS
Principal Investigator
University of California, Los Angeles
Steven Deeks, MD
Principal Investigator
University of California, San Francisco
Dennis Hartigan-O'Connor, MD, PhD
Principal Investigator
University of California, Davis